Clear, engaging, and practical updates on clinical psychiatry.

Subscribe for free on Apple Podcasts, Android, or Stitcher. Let us know what you think and suggest topics by taking the Podcast Survey.

Previous Post
Next Post

What You Need to Know About Kloxxado

Podcast, Volume , Number ,

Print Friendly, PDF & Email


On April 30th of this year, the FDA approved Kloxxado, a naloxone nasal spray that contains 8mg of naloxone per dose, which is twice as much as the most common formulation: Narcan. But what distinguishes Kloxxado distinguishes from the many other ways that naloxone is delivered and why was it developed in the first place?

Published On: 8/16/2021

Duration: 21 minutes, 01 seconds

Articles Referenced:A New High-Dose Naloxone: Life Saver or Punishment?,” The Carlat Addiction Treatment Report,” July/August 2021;

Naloxone Prescribing,” The Carlat Addiction Treatment Report,” July/August 2021

Got feedback? Take the podcast survey.


Leave A Comment